These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
514 related articles for article (PubMed ID: 36442487)
21. Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis. Li SC Pediatr Clin North Am; 2018 Aug; 65(4):757-781. PubMed ID: 30031497 [TBL] [Abstract][Full Text] [Related]
22. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review. Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039 [TBL] [Abstract][Full Text] [Related]
24. Recent advances in the diagnosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma): a review. Tan A; Denton CP; Mikhailidis DP; Seifalian AM Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S66-74. PubMed ID: 21586221 [TBL] [Abstract][Full Text] [Related]
25. Systemic sclerosis: one year in review 2023. Di Battista M; Lepri G; Codullo V; Da Rio M; Fiorentini E; Della Rossa A; Guiducci S Clin Exp Rheumatol; 2023 Aug; 41(8):1567-1574. PubMed ID: 37199215 [TBL] [Abstract][Full Text] [Related]
26. [Systemic sclerosis : What is currently available for treatment?]. Becker MO Internist (Berl); 2016 Dec; 57(12):1155-1163. PubMed ID: 27796473 [TBL] [Abstract][Full Text] [Related]
27. [Modern perspective on the development conditions and diagnosis of systemic sclerosis]. Wielosz E Wiad Lek; 2017; 70(4):855-859. PubMed ID: 29064817 [TBL] [Abstract][Full Text] [Related]
28. Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course. Becker MO; Riemekasten G Expert Rev Clin Immunol; 2016; 12(2):115-35. PubMed ID: 26558747 [TBL] [Abstract][Full Text] [Related]
29. Strategy for treatment of fibrosis in systemic sclerosis: Present and future. Yanaba K J Dermatol; 2016 Jan; 43(1):46-55. PubMed ID: 26782006 [TBL] [Abstract][Full Text] [Related]
30. Systemic sclerosis: Recent insights. Elhai M; Avouac J; Kahan A; Allanore Y Joint Bone Spine; 2015 May; 82(3):148-53. PubMed ID: 25557659 [TBL] [Abstract][Full Text] [Related]
31. Systemic sclerosis. Hughes M; Herrick AL Br J Hosp Med (Lond); 2019 Sep; 80(9):530-536. PubMed ID: 31498665 [TBL] [Abstract][Full Text] [Related]
33. Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors. Maria ATJ; Partouche L; Goulabchand R; Rivière S; Rozier P; Bourgier C; Le Quellec A; Morel J; Noël D; Guilpain P Front Immunol; 2018; 9():3112. PubMed ID: 30687318 [TBL] [Abstract][Full Text] [Related]
35. [Some aspects of systemic and localized (limited) sclerosis in children]. Kwiatkowska M; Rutkowska-Sak L; Zuber Z Ann Acad Med Stetin; 2012; 58(1):23-7. PubMed ID: 23547390 [TBL] [Abstract][Full Text] [Related]
36. Advances in the diagnosis and management of scleroderma-related vascular complications. Kerin K; Yost JH Compr Ther; 1998; 24(11-12):574-81. PubMed ID: 9847974 [TBL] [Abstract][Full Text] [Related]